Management and Treatment Considerations for Tachycardia Quiz

Tachycardia commonly presents with a rapid heartbeat.

Hypokalemia is a potential cause of ventricular tachycardia.

A rapid heart rate from the ventricles is termed ventricular tachycardia.

Placing ice packs on the face is not commonly used as a vagal maneuver to treat tachycardia.

Hypomagnesemia is commonly associated with tachycardia.

Bradycardia is not a potential cause of sinus tachycardia.

Calcium channel blockers primarily work by blocking calcium influx into cardiac cells in treating tachycardia.

Amiodarone is a common medication for managing supraventricular tachycardia.

The general approach involves vagal maneuvers and pharmacologic therapy for stable tachycardia.

Peripheral edema is not a potential complication of untreated tachycardia.

Hypokalemia is a potential complication of antiarrhythmic medication therapy for tachycardia.

The recommended immediate intervention for unstable tachycardia is synchronized cardioversion.

Immediate defibrillation is the preferred treatment for unstable ventricular tachycardia.

Class I antiarrhythmic medications primarily target sodium channels and are used to treat ventricular tachycardia.

Beta-blockers primarily work by decreasing cardiac output in treating tachycardia.

The primary goal is to restore sinus rhythm in treating atrial fibrillation-induced tachycardia.

Beta-blockers are the first-line pharmacological treatment for atrial fibrillation with rapid ventricular response.

Metoprolol is commonly used for rate control in atrial fibrillation and atrial flutter.

Amiodarone infusion is the mainstay treatment for ventricular tachycardia associated with a pulse and stable hemodynamics.